Items 51 to 60 of 500 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Hydrazino Adenosine | 15763-11-8 | sc-220737 | 50 mg | $300.00 | ||
2-Hydrazino Adenosine is a useful synthetic intermediate | ||||||
5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone Oxime | 61747-22-6 | sc-210357 | 250 mg | $360.00 | ||
5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone Oxime is a Fluvoxamine intermediate | ||||||
Allyl b-galactopyranoside | 2595-07-5 | sc-284952 sc-284952A | 500 mg 1 g | $100.00 $143.00 | ||
(S)-1-[(4-Chlorophenyl)phenylmethyl]piperazine | 439858-21-6 | sc-361826 | 25 mg | $267.00 | ||
(S)-1-[(4-Chlorophenyl)phenylmethyl]piperazine is (S)-1-[(4-Chlorophenyl)phenylmethyl]piperazine is an intermediate in the production of (S)-Cetirizine. | ||||||
2,3,4,6-Tetra-O-benzyl-1-deoxynojirimycin Hydrochloric Acid Salt | 72983-76-7 | sc-213985 | 20 mg | $360.00 | ||
2,3,4,6-Tetra-O-benzyl-1-deoxynojirimycin Hydrochloric Acid Salt is an intermediary compound in the preparation of Deoxynojirimycin | ||||||
1,2-Benzenediamine-15N2 | 116006-97-4 | sc-208718 sc-208718A sc-208718B sc-208718C sc-208718D sc-208718E | 5 mg 50 mg 100 mg 1 g 2.5 g 5 g | $352.00 $2453.00 $3932.00 $7298.00 $13673.00 $26525.00 | ||
1,2-Benzenediamine-15N2 is a carcinogenic compound | ||||||
Allyl α-D-Glucopyranoside | 7464-56-4 | sc-221239 | 1 g | $380.00 | ||
Allyl α-D-Glucopyranoside is a useful synthetic intermediate for oligosaccharide synthesis | ||||||
JHW 007 hydrochloride | 202645-74-7 | sc-362752 sc-362752A | 10 mg 50 mg | $183.00 $771.00 | ||
JHW 007 hydrochloride is JHW 007 hydrochloride is a dopamine uptake inhibitor with a high binding affinity for the dopamine transporter (DAT) with a Ki of 25 nM. | ||||||
[3R(1′R,4R)]-(+)-4-Acetoxy-3-[1-(tert-butyldimethylsilyloxy)ethyl]-2-azetidinone | 76855-69-1 | sc-254559 | 1 g | $84.00 | ||
1-(Diphenylmethyl)piperazine | 841-77-0 | sc-253871 | 100 g | $86.00 | ||
1-(Diphenylmethyl)piperazine is an intermediate for use in synthesis | ||||||